Abstract:Clinical trials serve as the fundamental prerequisite for clinical therapy of human disease, which is primarily based on biomedical studies in animal models. Undoubtedly, animal models have made a significant contribution to gaining insight into the developmental and pathophysiological understanding of human diseases. However, none of the existing animal models could efficiently simulate the development of human organs and systems due to a lack of spatial information; the discrepancy in genetic, anatomic, and physiological basis between animals and humans limits detailed investigation. Therefore, the translational efficiency of the research outcomes in clinical applications was significantly weakened, especially for some complex, chronic, and intractable diseases. For example, the clinical trials for human fragile X syndrome (FXS) solely based on animal models have failed such as mGluR5 antagonists. To mimic the development of human organs more faithfully and efficiently translate in vitro biomedical studies to clinical trials, extensive attention to organoids derived from stem cells contributes to a deeper understanding of this research. The organoids are a miniaturized version of an organ generated in vitro, partially recapitulating key features of human organ development. As such, the organoids open a novel avenue for in vitro models of human disease, advantageous over the existing animal models. The invention of organoids has brought an innovative breakthrough in regeneration medicine. The organoid-derived human tissues or organs could potentially function as invaluable platforms for biomedical studies, pathological investigation of human diseases, and drug screening. Importantly, the study of regeneration medicine and the development of therapeutic strategies for human diseases could be conducted in a dish, facilitating in vitro analysis and experimentation. Thus far, the pilot breakthrough has been made in the generation of numerous types of organoids representing different human organs. Most of these human organoids have been employed for in vitro biomedical study and drug screening. However, the efficiency and quality of the organoids in recapitulating the development of human organs have been hindered by engineering and conceptual challenges. The efficiency and quality of the organoids are essential for downstream applications. In this article, we highlight the application in the modeling of human neurodegenerative diseases (NDDs) such as FXS, Alzheimer’s disease (AD), Parkinson’s disease (PD), and autistic spectrum disorders (ASD), and organoid-based drug screening. Additionally, challenges and weaknesses especially for limits of the brain organoid models in modeling late onset NDDs such as AD and PD., and future perspectives regarding human brain organoids are addressed.

Organotypic culture of human brain explants as a preclinical model for AI-driven antiviral studies

Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study

iPSC-derived three-dimensional brain organoid models and neurotropic viral infections

Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid Β Associated Neuropathology and Phenotypic Rescue.

Human cerebral organoids — a new tool for clinical neurology research

Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations

Development of a high-throughput, quantitative platform using human cerebral organoids to study virus-induced neuroinflammation in Alzheimer’s disease

Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure.

Cerebral organoids for modeling of HSV-1-induced-multiscale neuropathology associated with Alzheimer’s disease and phenotypic rescue

Advancements in organs-on-chips technology for viral disease and anti-viral research

Organotypic culture of post-mortem adult human brain explants exhibits synaptic plasticity

Human post-mortem organotypic brain slice cultures: a tool to study pathomechanisms and test therapies

Novel Multiparametric Bioelectronic Measurement System for Monitoring Virus-Induced Alterations in Functional Neuronal Networks

A robust ex vivo experimental platform for molecular-genetic dissection of adult human neocortical cell types and circuits

Brain organoids: Human 3D models to investigate neuronal circuits assembly, function and dysfunction

An in Vivo Model of Functional and Vascularized Human Brain Organoids.

Engineered 3D Immuno-Glial-Neurovascular Human miBrain Model

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening

A Human Brain-Chip for modelling brain pathologies and screening of BBB crossing therapeutic strategies

The Promise and Potential of Brain Organoids

In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine